The Bredesen Protocol™ Next Generation Protocol developed by the Inventors of MEND
The Protocol provides a comprehensive personalized program designed to improve cognition and reverse the cognitive decline of SCI, MCI, and early Alzheimer’s disease. Continued research and testing by Dr. Bredesen began by evolving MEND into The Bredesen Protocol™, which has identified new and previously unrecognized causes of Alzheimer’s disease.
Additional Information
Click on the items below for a brief introduction to the title subject and links to the complete reference.
Reversal of cognitive decline: A novel therapeutic program
August 22, 2017
Inhalational Alzheimer’s disease: An unrecognized—and treatable—epidemic
August 22, 2017
Metabolic profiling distinguishes three subtypes of Alzheimer’s disease
August 22, 2017
Another Role for ApoE?
August 22, 2017
Direct Transcriptional Effects of Apolipoprotein E
August 22, 2017
Prionic Loops, Anti-Prions, and Dependence Receptors in Neurodegeneration
August 22, 2017
Next generation therapeutics for Alzheimer’s disease
August 22, 2017
Reversal of Cognitive Decline in Alzheimer’s Disease
August 22, 2017
On the Cover of Business in Savannah
January 15, 2014
A Balancing Act – Could the Secret Happy Aging Lie in Hormones?